{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/roundworm/background-information/prevalence/","result":{"pageContext":{"chapter":{"id":"b314674f-6a66-5ddd-8802-304c3e426573","slug":"prevalence","fullItemName":"Prevalence","depth":2,"htmlHeader":"<!-- begin field 3e535395-5282-4894-a884-22edf3e18c59 --><h2>How common is it?</h2><!-- end field 3e535395-5282-4894-a884-22edf3e18c59 -->","summary":"","htmlStringContent":"<!-- begin item 051da65b-5605-42ae-82fe-9a8a07502cb9 --><!-- begin field 1f87741d-870c-4a20-a85c-0d84cfb8a19f --><ul><li>An estimated 807 million–1.2 billion people in the world are infected with <em>Ascaris lumbricoides</em>.<ul><li><em>Ascaris </em>infection is most prevalent in tropical and subtropical areas (such as parts of Africa, China, South East Asia and Central and South America) where water supplies and sanitation are poor.</li></ul></li><li>Roundworm infections are rare in the UK and infections diagnosed in the UK are likely to have been acquired abroad — travellers and migrant populations are most often affected.<ul><li>Public Health England estimates that up to 20% of migrants from endemic countries may have helminth infections at the time of their arrival in the UK.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/roundworm/references/\">Dold, 2011</a>]  [<a class=\"bibliography-reference internal-reference\" href=\"/topics/roundworm/references/\">PHE, 2014</a>]  [<a class=\"bibliography-reference internal-reference\" href=\"/topics/roundworm/references/\">Lamberton, 2015</a>]  [<a class=\"bibliography-reference internal-reference\" href=\"/topics/roundworm/references/\">BMJ Best Practice, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/roundworm/references/\">WHO, 2017</a>] </p><!-- end field 1f87741d-870c-4a20-a85c-0d84cfb8a19f --><!-- end item 051da65b-5605-42ae-82fe-9a8a07502cb9 -->","topic":{"id":"0b211593-0490-51d7-b385-77c1348d2916","topicId":"86f28514-c082-4e71-b9cd-719bb23d733c","topicName":"Roundworm","slug":"roundworm","lastRevised":"Last revised in March 2018","chapters":[{"id":"afd49a93-1ce9-52fb-a055-fd1c76b80671","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"1ca90307-5054-5e96-b8dd-dd26ab3d1f37","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"1010fb00-03a7-5c59-97d2-ea8736818f7f","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"fcf66603-b24e-52b0-942c-0dceaa8b4806","slug":"changes","fullItemName":"Changes"},{"id":"4fdfdf72-543e-5751-862c-8eaf13924be5","slug":"update","fullItemName":"Update"}]},{"id":"f0c73b2e-d0b4-5256-825b-0bcbf3883393","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"32a5dbfc-b56c-5a5b-8ee0-4b768b4468c1","slug":"goals","fullItemName":"Goals"},{"id":"f6c04a04-26e6-5ff9-a76f-a932889ed88e","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"a6e7c9cd-07e3-5d6c-8cb8-ad0f52d578f2","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"1159fcbf-f459-54b9-aa2f-9bd9d0b1a8e3","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"fcdaab1c-f591-5be8-a3d0-3f10c883b3b0","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"ec7319d4-7df2-5bb3-869a-fada8fe9f07f","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"09423897-d040-5e23-a0b6-03704f13f695","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"d2968d4d-dcb0-5a48-b4b2-b5e12b9fd7d2","slug":"definition","fullItemName":"Definition"},{"id":"b314674f-6a66-5ddd-8802-304c3e426573","slug":"prevalence","fullItemName":"Prevalence"},{"id":"8af7691c-9282-57c4-8466-ed48646c2c72","slug":"complications-prognosis","fullItemName":"Complications and prognosis"}]},{"id":"e0cad7a2-094e-550d-8c50-ba0f3278d0b0","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"7f61aeea-2812-5894-b982-7eac0773650d","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"dfa31378-1010-522a-8f36-2b20d6b5c2eb","slug":"assessment","fullItemName":"Assessment"},{"id":"8acaa138-5187-5cdd-bffa-c02644a54d4f","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"737457d9-1adf-55dc-843b-f8cf0d0f0b35","fullItemName":"Management","slug":"management","subChapters":[{"id":"79acd68c-68c1-58c6-81c4-96f7d1e3c03d","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"f47f896a-c977-5285-8fb9-21b2b815f170","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"062f1c7c-5a5a-521f-9d2c-815df20a1944","slug":"mebendazole","fullItemName":"Mebendazole"}]},{"id":"54998378-f714-526f-a713-03c32c13ca38","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"55f9cf11-b8d2-5f00-9ff3-f71c57c598e4","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"b42e1d14-47ae-5d8b-9e31-86cff0ef4960","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"2fc87dbd-6994-5029-9187-d21de2f7ad29","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"d77b979b-90a8-5d4a-8909-15443afbea3e","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"4b8522b3-90b4-57dc-9555-6777601eceaf","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"da76e4e5-0180-5a7f-a705-ecfd7ef5f874","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"9d170f5f-3234-5149-858e-e60968697286","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"09423897-d040-5e23-a0b6-03704f13f695","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}